Adams Street Partners LLC Buys Shares of 1,711,430 Billiontoone, Inc. $BLLN

Adams Street Partners LLC purchased a new position in shares of Billiontoone, Inc. (NASDAQ:BLLN) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 1,711,430 shares of the company’s stock, valued at approximately $140,063,000. Billiontoone comprises about 53.1% of Adams Street Partners LLC’s investment portfolio, making the stock its biggest position. Adams Street Partners LLC owned about 3.74% of Billiontoone at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Rossby Financial LCC acquired a new position in shares of Billiontoone during the 4th quarter worth approximately $25,000. Nano Cap New Millennium Growth Fund L P acquired a new position in shares of Billiontoone during the 4th quarter worth approximately $82,000. Renaissance Capital LLC acquired a new position in shares of Billiontoone during the 4th quarter worth approximately $201,000. Sigma Planning Corp acquired a new position in shares of Billiontoone during the 4th quarter worth approximately $409,000. Finally, New York State Common Retirement Fund acquired a new position in shares of Billiontoone during the 4th quarter worth approximately $419,000.

Insider Buying and Selling

In other news, insider Nancy Joann Johnson sold 10,582 shares of Billiontoone stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $100.47, for a total transaction of $1,063,173.54. Following the sale, the insider directly owned 21,900 shares of the company’s stock, valued at approximately $2,200,293. This trade represents a 32.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Oguzhan Atay sold 12,500 shares of Billiontoone stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $98.22, for a total value of $1,227,750.00. Following the sale, the insider directly owned 187,500 shares in the company, valued at $18,416,250. The trade was a 6.25% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 60,750 shares of company stock worth $5,979,598 in the last ninety days.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Guggenheim boosted their target price on Billiontoone from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, May 13th. Wells Fargo & Company decreased their target price on Billiontoone from $110.00 to $90.00 and set an “equal weight” rating on the stock in a report on Thursday, March 5th. Wall Street Zen raised Billiontoone from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. JPMorgan Chase & Co. boosted their target price on Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Finally, BTIG Research decreased their target price on Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a report on Thursday, May 7th. Six investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Billiontoone presently has a consensus rating of “Moderate Buy” and an average price target of $125.29.

Billiontoone Stock Performance

BLLN opened at $101.12 on Friday. The firm has a market cap of $4.65 billion and a P/E ratio of 183.85. Billiontoone, Inc. has a 52-week low of $61.96 and a 52-week high of $138.70. The company has a debt-to-equity ratio of 0.18, a quick ratio of 10.58 and a current ratio of 10.92. The business’s fifty day moving average is $88.03 and its 200-day moving average is $88.20.

Billiontoone (NASDAQ:BLLN) last released its earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.33. The company had revenue of $108.39 million for the quarter, compared to analyst estimates of $95.81 million. During the same period last year, the company posted ($0.39) earnings per share. The business’s revenue for the quarter was up 83.8% compared to the same quarter last year. Sell-side analysts expect that Billiontoone, Inc. will post 0.93 EPS for the current fiscal year.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.